Academic Journal
Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial
العنوان: | Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial |
---|---|
المساهمون: | Eugene Han, Ji Hye Huh, Eun Y Lee, Ji C Bae, Sung W Chun, Sung H Yu, Soo H Kwak, Kyong S Park, Byung-Wan Lee, Lee, Byung Wan |
بيانات النشر: | Wiley-Blackwell |
سنة النشر: | 2022 |
مصطلحات موضوعية: | Diabetes Mellitus, Type 2* / complications, Type 2* / drug therapy, Dipeptidyl-Peptidase IV Inhibitors* / adverse effects, Double-Blind Method, Humans, Liver, Non-alcoholic Fatty Liver Disease* / complications, Non-alcoholic Fatty Liver Disease* / drug therapy, Piperazines, dipeptidyl peptidase-4 inhibitor, evogliptin, magnetic resonance imaging-derived proton density fat fraction, non-alcoholic fatty liver disease, pioglitazone, type 2 diabetes |
الوصف: | restriction |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 1462-8902 1463-1326 |
Relation: | DIABETES OBESITY & METABOLISM; J00722; OAK-2022-01593; https://ir.ymlib.yonsei.ac.kr/handle/22282913/188336; T202200885; DIABETES OBESITY & METABOLISM, Vol.24(4) : 752-756, 2022-04 |
DOI: | 10.1111/dom.14623 |
الاتاحة: | https://ir.ymlib.yonsei.ac.kr/handle/22282913/188336 https://doi.org/10.1111/dom.14623 https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14623 |
Rights: | CC BY-NC-ND 2.0 KR |
رقم الانضمام: | edsbas.CD5906A9 |
قاعدة البيانات: | BASE |
تدمد: | 14628902 14631326 |
---|---|
DOI: | 10.1111/dom.14623 |